Martek Biosciences MATK
-
Wall Street Breakfast: Must-Know News
… of approximately $6.3B. Royal DSM buys Martek. Royal DSM (RDSMY.PK) agreed to buy nutrition supplier Martek Biosciences ( MATK ) for $31.50/share in cash, or $1.09B, marking a 35% premium to Martek's closing price yesterday …
-
New Morningstar Analyst Report - Martek Biosciences Corporation
… best interests of Martek shareholders in the future. Martek Biosciences develops and markets nutritional products for the infant ..... versions of these acids could harm Martek's market share. Martek Biosciences dominates the domestic infant formula market with its …
-
Solid 4Q for Martek, but Lower-Than-Expected Quarterly Outlook Weighs on Shares
Martek Biosciences ' MATK fourth-quarter revenue and earnings, excluding a restructuring charge, came in above our expectations. However, the midpoint …
-
Solid 3Q for Martek
Martek Biosciences MATK posted good third - quarter results that matched our estimates . However , the firm's range of fourth - quarter projections came …
-
Strong 2Q for Martek
Martek Biosciences MATK recently reported strong second-quarter results that outperformed our expectations. We will consider raising our fair value …
-
Martek Acquires Amerifit Brands
Martek Biosciences MATK announced Thursday that it plans to acquire Amerifit Brands, a health and wellness company, from a private equity firm and announced …
-
Potential Improvement in Martek's 4Q
Martek Biosciences MATK plans to report fourth-quarter results soon. We expect total revenue growth to improve sequentially, but think year-over …
-
Formula Sales Hurt Martek's 3Q
Martek MATK reported third-quarter results Wednesday with revenues coming in slightly lower than we expected. Given this trend and expectations …
-
ARSVX Aston/River Road Small Cap Value N Fund Analysis, Report, Research, 5 Star Rating – Morningstar
… names. For example, though management typically shies away from the risk of biotech stocks, it still bought Martek Biosciences MATK . The key is that Martek is not a bio-tech firm but rather a small manufacturer of Omega-3 nutritional additives …
-
Weak Trends in Martek's 2Q
Martek Biosciences MATK reported decent second-quarter results and announced full-year projections that came in slightly under our forecast. These …